finance

Revenue Up 22 per cent, PAT Up 82 per cent Thyrocare delivered a robust performance in Q2FY26 with consolidated revenue of Rs 216.53 crore, registering a strong 22 per cent year-on-year growth, led by continued momentum in the Pathology segment, which grew 24 per cent YoY. Normalised EBITDA rose sharply by 49 per cent YoY […]

The company further solidifies its commitment to maintaining a robust capital structure, thereby fueling innovation-led growth Medi Assist Healthcare Services announced an investment from Massachusetts Institute of Technology (MIT) and 238 Plan Associates (an affiliate of MIT). The aggregate investment of Rs 198 crores was secured through a preferential allotment on a private placement basis. […]

While the uniform rate has been positioned as a reform to simplify taxation, domestic manufacturers highlight that inputs for device manufacturing are taxed at 18 per cent The GST Council’s decision to bring all medical devices under a uniform 5 per cent slab has been welcomed by industry stakeholders, though manufacturers continue to raise concerns […]

Q1 adjusted net profit was at Rs 29,961 million, up 5.7 per cent YoY Sun Pharmaceutical Industries reported financials for the first quarter ending June 30, 2025. Highlights of Q1FY26 consolidated financials ·         Gross sales at Rs 137,861 million, growth of 10.1 per cent ·         India formulation sales at Rs 47,211 million, up 13.9 per cent ·         US formulation sales at $ 473 million, up 1.4 per cent ·         Global Innovative Medicines sales at $ 311 million, up 16.9 per cent, accounting for 19.3 per cent of Q1FY26 sales ·         Emerging Markets formulation sales at $ 298 million, up 5.1 per cent ·         Rest of World formulation sales at $ 219 million, up 15.5 per cent ·         R&D investments at Rs 9,029 million or 6.5 per cent of sales compared to Rs 7,940 million for Q1FY25 ·         EBITDA at Rs 43,017 million (including other operating revenues), up 19.2 per cent, with a resulting EBITDA margin of 31.1 per cent. ·         Profit before exceptional items and tax was Rs 39,908 million up 16.6per cent ·         Adjusted net profit (excluding the exceptional items) for Q1FY26 was Rs 29,961 million, up 5.7 […]

EBITDA grew 14.8 per cent YoY to Rs 2,181 million Strides Pharma Science announced its consolidated financial results for the quarter (Q1FY26) ended June 30, 2025. Q1FY2026 Performance Highlights §  Revenue at Rs 11,197 million, grew 6.2 per cent YoY §  Absolute gross margin at Rs 6,755 million, grew 11.7% YoY §  Gross margin improved to 60.3 per […]

The consolidated gross margin stood at 71 per cent with reported EBITDA margin at 30 per cent Thyrocare Technologies has announced the results for the quarter ended June 30, 2025. In Q1FY26, the consolidated revenue saw a YoY increase of 23 per cent, driven by a 25 per cent growth in pathology and a 6 per […]

The funds will be used to strengthen technology, expand marketing efforts, grow the team, and support working capital needs Jobizo, a leading healthtech HR platform, has raised Rs 12 crores in its Pre-Series A round from Inflection Point Ventures (IPV) and Alkemi Ventures. The funds will be deployed to accelerate product innovation, scale marketing efforts, […]

The proceeds from the QIP will be utilised for repayment, pre-payment or redemption, in full or in part, of certain outstanding financial instruments etc Biocon has completed its Qualified Institutions Placement (QIP), raising Rs 4,500 crore through the issuance of 13,63,63,635 equity shares of face value Rs 5 each to eligible qualified institutional buyers at […]

Fin-health startup delivers 30 per cent to 40 per cent cost savings to patients while posting $3 million ARR, positioning for company-wide profitability within four months Mykare, one of India’s leading fin-health startups revolutionising healthcare accessibility for the missing middle class, has announced that it has achieved EBITDA-positive status in its flagship elective surgery vertical. […]

HealthKois will accelerate India’s healthcare evolution by investing in technology-enabled, scalable, and high-impact enterprises HealthKois, India’s premier healthcare transformation fund, has launched with a target corpus of $300 million, and an additional green shoe option of $100 million. The fund has been established by the key leadership team behind HealthQuad—Charles Janssen (Managing Partner), Ajay Mahipal (Partner) […]